Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
13.96
-0.17 (-1.20%)
Aug 10, 2026, 4:00 PM EDT - Market closed
Bioventus Revenue
Bioventus had revenue of $153.21M in the quarter ending June 27, 2026, with 3.76% growth. This brings the company's revenue in the last twelve months to $581.85M, up 3.14% year-over-year. In the year 2025, Bioventus had annual revenue of $568.09M, down -0.91%.
Revenue (ttm)
$581.85M
Revenue Growth
+3.14%
P/S Ratio
2.02
Revenue / Employee
$618,987
Employees
940
Market Cap
1.17B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 568.09M | -5.19M | -0.91% |
| Dec 31, 2024 | 573.28M | 60.94M | 11.89% |
| Dec 31, 2023 | 512.35M | 228.00K | 0.04% |
| Dec 31, 2022 | 512.12M | 81.22M | 18.85% |
| Dec 31, 2021 | 430.90M | 109.74M | 34.17% |
| Dec 31, 2020 | 321.16M | -18.98M | -5.58% |
| Dec 31, 2019 | 340.14M | 20.96M | 6.57% |
| Dec 31, 2018 | 319.18M | 65.53M | 25.83% |
| Dec 31, 2015 | 253.65M | 10.76M | 4.43% |
| Dec 31, 2014 | 242.89M | 10.52M | 4.53% |
| Dec 31, 2013 | 232.38M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| QuidelOrtho | 2.67B |
| Enovis | 2.30B |
| Integra LifeSciences Holdings | 1.65B |
| CONMED | 1.37B |
| Tandem Diabetes Care | 1.04B |
| Lumexa Imaging Holdings | 1.03B |
| Alphatec Holdings | 815.05M |
| Artivion | 471.47M |
BVS News
- 4 days ago - Bioventus price target raised to $18 from $16 at Craig-Hallum - TheFly
- 4 days ago - Bioventus price target raised to $18 from $14 at Barrington - TheFly
- 5 days ago - Bioventus reports Q2 EPS 22c, consensus 22c - TheFly
- 5 days ago - Bioventus backs FY26 adjusted EPS view 75c-79c, consensus 78c - TheFly
- 5 days ago - Bioventus initiates review of strategic alternatives - TheFly
- 5 days ago - Bioventus Earnings Call Transcript: Q2 2026 - Transcripts
- 5 days ago - Bioventus Earnings release: Q2 2026 - Filings
- 5 days ago - Bioventus Quarterly report: Q2 2026 - Filings